Health Condition 1: J453- Mild persistent asthma
Conditions
Interventions
Intervention1: Habb-e-Banafsha: 2 tablets orally thrice daily with lukewarm water for four weeks
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects of either sex between the age group of 18-65 years. 2. Subjects of Bronchial Asthma for at least 6 months presenting with at least one of the following symptoms: Wheeze Shortness of breath Chest tightness and cough that vary over time and in intensity, Expiratory airflow limitation as suggested by a decreased FEV1 3. Objective evidence for reversible airway obstruction (>=12% and >=200 mL change in FEV1 and/or a 25% and 60 L/min change in PEFR) either spontaneously or after treatment. 4. Subjects with Asthma Control Questionnaire Score > 1.5
Exclusion criteria
Exclusion criteria: 1. FEV1/FVC ratio 2. Pregnant and lactating females 3. Subjects with other Respiratory Tract Infections, tuberculosis and malignancy. 4. Subjects of Presence of chronic cough with expectoration for 2-3 months in each of two successive years. 5. Subjects with co-morbidities; Diabetes Mellitus, Hepatic and Renal Insufficiency 6. Subjects with known interstitial lung disease. 7. Subjects with Tobacco Smoking. 8. Subjects with known chronic obstructive pulmonary disease (COPD) 9. Patient with regular use of oral or systemic corticosteroids for conditions other than Asthma. 10. Subjects who are not willing to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in signs and symptoms of Zeeq un-Nafas Rewi (Bronchial Asthma)Timepoint: 1 week | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and after four weeks | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed